NASDAQ:PPH VanEck Pharmaceutical ETF (PPH) Price, Holdings, & News → The Small Biotech with a BIG Cancer Solution (From Behind the Markets) (Ad) Free PPH Stock Alerts $90.88 -0.01 (-0.01%) (As of 09:58 AM ET) Add Compare Share Share Today's Range$90.77▼$91.0350-Day Range$84.25▼$90.8952-Week Range$74.05▼$91.03Volume15,948 shsAverage Volume130,540 shsMarket Capitalization$471.67 millionAssets Under Management$543.66 millionDividend Yield1.87%Net Expense Ratio0.35% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media Get VanEck Pharmaceutical ETF alerts: Email Address About VanEck Pharmaceutical ETF (NASDAQ:PPH)The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.Read More PPH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PPH ETF News HeadlinesMarch 7, 2024 | investorplace.comThe Top 3 ETFs to Buy in March 2024February 28, 2024 | markets.businessinsider.com11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher YieldsMarch 28, 2024 | DTI (Ad)CBOE shift unlocks new weekend income strategyYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. You're probably wondering, “Okay… But how does that affect me?” This perk now allows everyday traders like yourself to target extra income over the weekend. February 28, 2024 | stocknews.comNavigate to Success With These 4 Pharma Stocks to BuyFebruary 26, 2024 | investorplace.comThe 3 Hottest Healthcare ETFs to Buy in 2024February 21, 2024 | seekingalpha.comPPH VanEck Pharmaceutical ETFFebruary 20, 2024 | msn.comHealthcare dealmakers see increased M&A, valuations in 2024: KPMGJanuary 28, 2024 | msn.comBig Pharma earnings season in spotlight amid positive sentimentMarch 28, 2024 | Crypto 101 Media (Ad)Major Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.January 8, 2024 | finance.yahoo.com5 ETF Zones Scaling New Highs at the Start of 2024See More Headlines Receive PPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Pharmaceutical ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerVan Eck Fund NameVanEck Pharmaceutical ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:PPH Inception Date12/20/2011 Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin WebN/A Phone14089961010Fund Focus Asset ClassEquity BenchmarkMarket Vectors US Listed Pharmaceutical 25 Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionGlobal Number of Holdings26 Fund Statistics Assets Under Management$529.36 million Average Daily Volume$126,690.80 Discount/Premium0.02% Administrator, Advisor and Custodian AdministratorVan Eck Associates Corporation AdvisorVan Eck Associates Corporation CustodianState Street Bank and Trust Company DistributorVan Eck Securities Corporation Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerIMC Options OptionableOptionable Options Volume2 Put Options1 Call Options2 Short Interest1,720,000 shs Miscellaneous Outstanding Shares5,190,000Beta0.72 Creation Unit50,000 Creation Fee$500.00 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Ad Crypto 101 MediaAltcoin FRENZY Alert…Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days… Click here now to register for the event (FOR FREE!) VanEck Pharmaceutical ETF ExpensesTypePPHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.35%0.57%0.54%0.48%0.51%Other Expenses0.00%0.40%0.54%0.32%0.58%Total Expense0.35%0.72%0.70%0.57%0.70%Fee Waiver0.00%-0.53%-0.54%-0.20%-0.56%Net Expense0.35%0.61%0.60%0.54%0.58% VanEck Pharmaceutical ETF (PPH) Holdings & ExposureTop 10 PPH HoldingsTeva Pharmaceutical Industries(NYSE:TEVA)Holding Weight: 5.34%AbbVie(NYSE:ABBV)Holding Weight: 5.21%Johnson & Johnson(NYSE:JNJ)Holding Weight: 5.14%Novartis AG ADRHolding Weight: 4.95%Eli Lilly and Company(NYSE:LLY)Holding Weight: 4.92%McKesson(NYSE:MCK)Holding Weight: 4.86%Sanofi(NASDAQ:SNY)Holding Weight: 4.79%Novo Nordisk A/S(NYSE:NVO)Holding Weight: 4.78%Zoetis(NYSE:ZTS)Holding Weight: 4.76%AmerisourceBergen CorporationHolding Weight: 4.74%PPH Sector ExposurePPH Industry ExposureFull Holdings Details Similar ETFsVanEck Biotech ETFNASDAQ:BBHInvesco S&P SmallCap Health Care ETFNASDAQ:PSCHInvesco Dorsey Wright Healthcare Momentum ETFNASDAQ:PTHProShares Ultra Nasdaq BiotechnologyNASDAQ:BIBPrincipal Healthcare Innovators ETFNASDAQ:BTECInstitutional OwnershipCoreFirst Bank & TrustBought 7,800 shares on 3/18/2024Ownership: 0.169%Goldman Sachs Group Inc.Sold 250,971 shares on 3/1/2024Ownership: 26.917%GSA Capital Partners LLPSold 3,345 shares on 2/16/2024Ownership: 0.190%DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am MainSold 600 shares on 2/16/2024Ownership: 0.034%Harbour Investments Inc.Bought 637 shares on 2/16/2024Ownership: 0.032%View All Institutional Transactions PPH ETF - Frequently Asked Questions How have PPH shares performed in 2024? VanEck Pharmaceutical ETF's stock was trading at $81.37 on January 1st, 2024. Since then, PPH stock has increased by 11.7% and is now trading at $90.89. View the best growth stocks for 2024 here. How often does VanEck Pharmaceutical ETF pay dividends? What is the dividend yield for VanEck Pharmaceutical ETF? VanEck Pharmaceutical ETF announced a quarterly dividend on Tuesday, December 26th. Shareholders of record on Thursday, December 28th will be given a dividend of $0.3074 per share on Friday, December 29th. This represents a $1.23 annualized dividend and a yield of 1.35%. The ex-dividend date is Wednesday, December 27th. Read our dividend analysis for PPH. What does PPH invest in? VanEck Pharmaceutical ETF is a equity fund issued by Van Eck. PPH focuses on health care investments and follows the Market Vectors US Listed Pharmaceutical 25 Index. The fund's investments total to approximately $543.66 million assets under management. What stocks does VanEck Pharmaceutical ETF hold? PPH invests in 26 holdings. Some of the stocks in their portfolio include Teva Pharmaceutical Industries (TEVA), AbbVie (ABBV), Johnson & Johnson (JNJ), Eli Lilly and Company (LLY), McKesson (MCK), Sanofi (SNY), Novo Nordisk A/S (NVO), Zoetis (ZTS), Merck & Co., Inc. (MRK). What is the management fee for VanEck Pharmaceutical ETF? VanEck Pharmaceutical ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for PPH is 0.35%. What is Bruce Gordon's approval rating as VanEck Pharmaceutical ETF's CEO? 38 employees have rated VanEck Pharmaceutical ETF Chief Executive Officer Bruce Gordon on Glassdoor.com. Bruce Gordon has an approval rating of 98% among the company's employees. This puts Bruce Gordon in the top 20% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of VanEck Pharmaceutical ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Pharmaceutical ETF investors own include Bank of America (BAC), Alibaba Group (BABA), AeroVironment (AVAV), Activision Blizzard (ATVI), ARK Innovation ETF (ARKK), Applied Materials (AMAT), Applied Graphene Materials (AGM), Air Canada (AC) and Abbott Laboratories (ABT). Who are VanEck Pharmaceutical ETF's major shareholders? VanEck Pharmaceutical ETF's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Goldman Sachs Group Inc. (26.92%), Goldman Sachs Group Inc. (26.92%), Healthcare of Ontario Pension Plan Trust Fund (6.15%), Avalon Trust Co (5.50%), Miller Investment Management LP (2.76%) and Prime Capital Investment Advisors LLC (2.69%). How do I buy shares of VanEck Pharmaceutical ETF? Shares of PPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PPH) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThe 3rd Revolution in WarfareWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBill Ackman’s 2024 warningPorter & CompanyWARNING - this content may be disturbingParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.